AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Minimum age of 18
* Women with placenta previa or low-lying placenta confirmed by TVS at 19-23 6/7 weeks of gestation.
Women attending Maternity Triage with vaginal bleeding at \< 32 weeks of gestation, with a diagnosis of placenta previa or low-lying placenta and not requiring an emergency delivery.
* Women with a normally located placenta at the II trimester ultrasound scan, at 19-23 6/7 week of gestation (control group)
* Single pregnancy
* Signature of the informed consent to participate in the study
Note: Women of the "control group" will be recruited in a 1:3 ratio. After the inclusion of 1 case, 3 women with a normally located placenta will be recruited, according to the parity of the woman representing the case (e.g.: 1 CASE= nulliparous woman, 3 CONTROLS= 3 nulliparous women).
Exclusion Criteria:
* Suspected or confirmed invasive placentation (i.e., placenta accreta)
* Vaginal bleeding requiring emergency delivery
* Inability to meet the conditions set out in the study protocol
What they're measuring
1
Incidence of vaginal delivery and urgent cesarean section
Timeframe: Until the end of the study (approximately 54 months).